| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HOC.2008.07.001 |
| P698 | PubMed publication ID | 18954745 |
| P2093 | author name string | Christian Schmidt | |
| Martin Dreyling | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mantle cell lymphoma | Q268713 |
| P304 | page(s) | 953-63, ix | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
| P1476 | title | Therapy of mantle cell lymphoma: current standards and future strategies | |
| P478 | volume | 22 |
| Q35206717 | Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivo |
| Q37763618 | Current treatment strategy and new agents in mantle cell lymphoma |
| Q33832937 | Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications |
| Q38055498 | Emerging agents for the treatment of mantle cell lymphoma |
| Q57118418 | Endoscopic findings in mantle cell lymphoma with gastrointestinal tract involvement |
| Q35007061 | In vitro and in vivo interactions between the HDAC6 inhibitor ricolinostat (ACY1215) and the irreversible proteasome inhibitor carfilzomib in non-Hodgkin lymphoma cells |
| Q37432231 | Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies |
| Q33937765 | Mantle cell lymphoma presenting as a saccular cyst |
| Q43067954 | Mantle cell lymphoma with multiple lymphomatous polyposis and intussusception: A case report |
| Q38132359 | Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance |
| Q64123976 | R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY |
| Q39045701 | Recommendations for Clinical Trial Development in Mantle Cell Lymphoma. |
| Q34168461 | Role of CAAT/enhancer binding protein homologous protein in panobinostat-mediated potentiation of bortezomib-induced lethal endoplasmic reticulum stress in mantle cell lymphoma cells. |
| Q54372017 | Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. |
| Q35146262 | Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma |
Search more.